Introduction
The risk of hospital personnel developing the acquired immune deficiency syndrome (AIDS) or antibodies to the human immunodeficiency virus (HIV) as a result of occupational exposure appears to be very low'. Antibodies to HIV have not been found in studies of staff working with seropositive patients in Britain2'3. However, the natural history of the disease and all possible modes of transmission may not be fully evaluated, and laboratory personnel are concerned about handling specimens from patients who have evidence of infection. The Advisory Committee on Dangerous Pathogens recommends special handling of specimens from patients with suspected AIDS4, including the use of containment level 3 facilities or a class 1 cabinet for specimen separation and manual tests. It advises that, wherever possible, analyses be confined to those performed in an enclosed system, e.g. an automatic analyser or cell counter which can be easily disinfected and operates without droplet dispersal. As few analysers at present work without the possibility of aerosol dispersal, this potentially limits the number of analyses available.
No specific advice is given about the handling of specimens from a second, much larger, group of people who have antibodies to HIV without obvious clinical effect, although this has been discussed by others5. -At present, some laboratories employ no special precautions whilst others strictly limit the analyses available. Another option worth consideration is the use of physical or chemical methods to decrease the pathogen's infectivity, and reduce the chance of infection after accidental inoculation of blood. Heat treatment at 56°C for 30 minutes and treatment with beta-propiolactone (BPL) are each capable of reducing the infectivity of HIV by inactivation of the reverse transcriptase activity6'7. BPL H2C-C = 0 H2C O BPL also reduces the infectivity of a wide range of other microorganisms8'9.
Methods
Specimens of venous blood were collected from 46 patients, many of whom had markedly abnormal renal or liver function tests or immunological abnormalities.
Whole blood anticoagulated with EDTA was used for routine haematological determinations, citrated plasma for coagulation studies, heparinized plasma for most biochemical determinations and serum for the measurement ofimmunoglobulin concentrations. (a) BPL treatment: The serum and plasma specimens were divided into 2 aliquots and 10 ,ul of BPL (Sigma Chemical Co) was added to one aliquot to attain a final concentration of 0.25%. Specimens were then left at 22°C for 3 hours. (b) Heat treatment: One aliquot of each specimen was placed in a waterbath at 560C for 30 minutes. The plasma specimens were then centrifuged.
Analysis of a wide range of parameters was performed in duplicate on a Monitor Parallel analyser using the manufacturers' recommended procedures'0. For 20 paired specimens, urea was also determined by a urease method, and plasma glucose was measured on a Beckman glucose analyser. Amylase was measured enzymatically on a Technicon RA 1000 analyser, and creatine kinase was measured using a Boehringer kit. Plasma thyroxine and triiodothyronine were measured by 'in-house' radioimmunoassay, and' phenytoin measured by fluoroimmunoassay on an Abbott TDX analyser. Immunoglobulin and complement concentrations were measured on a Beckman Immunochemistry Analysis II System using Beckman ICS reagent kits. Whole blood specimens were analysed on a Coulter S-plus counter, 6 and 24 hours after treatment, and blood films were also prepared. Kaolin cephalin clotting time (KCCT) and Quick's prothrombin time were also measured.
Results are expressed as the mean percentage difference resulting from the treatment, and statistical analysis was performed using the Wilcoxon paired signed rank test.
Results
The effects of both BPL and heat treatment on the analyses performed are shown in Table 1 .
Effects of BPL treatment: There was a significant decrease in bicarbonate results, and aspartate transaminase (AST), gamma-glutamyl transpeptidase (yGT) and lactate dehydrogenase (LDH) determinations were 5-20% lower on treated samples. This finding was constant and found on repeat analysis 24 hours later. There was no significant effect on many analytes including sodium, potassium, urea, Effects of heat treatment: This caused a greater alteration than BPL for most analytes except total bicarbonate. Activities of alkaline phosphatase and creatine kinase were virtually abolished. The measurement of complement components C3 and C4 was reduced by heating, and for C4 the results were significantly different and varied greatly between the various specimens. Heat treatment of whole blood often caused cell agglutination and rendered automated cell-counting and cross-matching impossible. It also altered coagulation studies because clotting factors are largely denatured at this temperature.
Discussion
Heat treatment at 560C for 30 minutes and BPL treatment have both been reported to inactivate the reverse-transcriptase activity of HIV6'7. This effect has been confirmed in plasma specimens using the preparation and concentration of BPL used in this study (Dr R Eglin, personal communication). The technician time required and the cost of BPL treatment are similar to those of heat treatment plus centrifugation. The number of specimens requiring treatment and the facilities of the particular laboratory will, however, affect this calculation. Separation of specimens must still be performed prior to treatment, and the details of this process considered. BPL must be handled with care, because large doses have caused neoplasia in some rodents'1, although there are no data in humans or primates. The products formed on hydrolysis in blood/plasma do not appear to be carcinogenic and the BPL should be degraded by the time specimens are handled in the routine laboratory. In West Germany, BPL has been used for many years to treat some blood products with no obvious problems. The BPL used for treatment must be stored at 40C in the concentrated form and inspected ifused infrequently because polymerization may occur in commercially available BPL.
Heat treatment is simple although care must be taken that the temperature is accurately controlled, or effects of different magnitude to those described will occur. Centrifugation of specimens is often needed after heat treatment because some coagulation and precipitation ofproteins may occur.
Both heat and BPL affect the results of some biochemical analyses. Heat treatment has considerably greater effects, however, particularly on the activity of enzymes. Even in patients with abnormal results, the 5-20% reduction seen with BPL will usually allow clinical interpretation, provided those effects are considered. The greater effect of heat treatment makes this less feasible, and for heat-labile enzymes such as creatine kinase and alkaline phosphatase the activity is virtually abolished. Heating and BPL have a similar effect on the assay of immunoglobulins, although the effect in individual patients with a paraprotein may vary.
BPL, unlike heating, has little effect on the determination of haemoglobin, white cell count, platelet count and red cell indices if specimens are analysed within 24 hours of treatment. Neither treatment is suitable for the preparation of blood for crossmatching or coagulation studies.
Disinfection of specimens either by treating with BPL or, in specific cases, by heat treatment could be performed on specimens from patients with 'suspected AIDS' or antibodies to HIV without-affecting the clinical value of many laboratory analyses. Such precautions could increase the availability of analyses in the routine laboratory.
